MDM2 is a well-known regulator that reduces p53 protein stability, and treatment with an MDM2 inhibitor stabilizes p53, leading to growth inhibition, apoptosis induction, and increased GEM sensitivity in PC cells [54]. Here, MDM2 is linked to pachyonychia congenita.